Urolithin A for longevity
Grade BA gut-microbiome metabolite of ellagitannins (pomegranate, walnuts) that triggers mitophagy — the selective recycling of damaged mitochondria.
A gut-microbiome metabolite of ellagitannins (pomegranate, walnuts) that triggers mitophagy — the selective recycling of damaged mitochondria.
Selectively induces mitophagy via PINK1/Parkin and mitochondrial biogenesis; improves muscle mitochondrial bioenergetics in aged tissue.
Urolithin A is typically taken orally as capsule (mitopure / synthetic urolithin a is most-studied), morning, with or without food. Selectively induces mitophagy via PINK1/Parkin and mitochondrial biogenesis; improves muscle mitochondrial bioenergetics in aged tissue. Effective range is 250 mg – 1,000 mg, with 500 mg AM being the most-studied dose. It does not require food, and fasted dosing is often preferred for absorption or timing reasons.
Morning or pre-training dosing aligns Urolithin A with circadian cortisol rise and training demand. This maximises subjective energy effects and avoids sleep interference.
Grade B — mechanism is credible and at least one human trial, pharmacokinetic study or strong observational evidence exists. Long-term effects on healthspan endpoints are still incomplete.
The primary references used to grade Urolithin A are listed below. Cross-check against the current literature and expect the grade to move as new human trials publish.
Further reading: Research library → · Protocols →
Common questions about dose, benefits, side effects and longevity use of Urolithin A.
500 mg AM is the most-studied dose, with a full effective range of 250 mg – 1,000 mg. Take it morning, with or without food.
Selectively induces mitophagy via PINK1/Parkin and mitochondrial biogenesis; improves muscle mitochondrial bioenergetics in aged tissue.
Subjective effects can appear in 1–3 weeks. Objective biomarker shifts typically require 8–12 weeks of consistent dosing, which is why baseline and 12-week labs are recommended.
Food is not required for Urolithin A. Many users prefer fasted dosing to keep timing consistent, but taking it with a light snack is fine.
Generally well tolerated; Mild GI effects rare. Avoid in: Pregnancy and lactation (insufficient data).
Most users run Urolithin A continuously and reassess every 12 weeks. A short wash-out can restore responsiveness if effects plateau. Long-term dosing should be paired with periodic bloods.
Commonly stacked with: Creatine monohydrate, Omega-3, NMN. Introduce one compound at a time to preserve attribution of effect and side effect.
Look for third-party testing (NSF, Informed Sport, USP), a standardised active compound on the label, a clear country of origin, and dose-per-serving that matches the researched range.
| Attribute | Urolithin AThis page | NMN | Creatine Monohydrate |
|---|---|---|---|
| Evidence | Grade B71/100 | Grade A87/100 | Grade A94/100 |
| Category | Mitochondrial | Mitochondrial | Cognition |
| Best for | Improved muscle endurance in middle-aged adults (RCT) | Restored NAD+ in aged tissues | Strength and lean mass |
| Typical dose | 500 mg AM | 250–500 mg AM | 5 g daily |
| Timing | Morning, with or without food | Morning, before training | Any time of day, consistent |
| Form | Capsule (Mitopure / synthetic urolithin A is most-studied) | Sublingual powder or enteric capsule | Micronized powder |
| Action | Current page | View → | View → |